longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Revvity Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

MarketWatch Automated
Jul 23, 2026 at 09:14 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Revvity Inc. (RVTY) shares rose 2.38% to $113.17 on Thursday, marking its third consecutive day of gains despite a broader market decline. The stock underperformed relative to competitors like Danaher and Agilent Technologies but outperformed IDEXX Laboratories. Trading volume exceeded the 50-day average. Revvity remains 4.34% below its 52-week high.

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Revvity Inc. (RVTY) rose 2.38% to $113.17 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.

This was the stock's third consecutive day of gains.

Revvity Inc. closed 4.34% below its 52-week high of $118.30, which the company reached on January 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Danaher Corp. (DHR) rose 7.46% to $192.50, IDEXX Laboratories Inc. (IDXX) fell 1.03% to $539.37, and Agilent Technologies Inc. (A) rose 4.71% to $139.74.

Trading volume (1.5 M) eclipsed its 50-day average volume of 1.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-23-26 1714ET

Login to unlock620characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Sep 11, 2026 at 03:00 AMORCL (Trans): OCI +121%, cash flow still -$5bn
  • Sep 10, 2026 at 10:44 AMSBUX: Retreat from China—Can the Coffee King Rebound on Home Turf?

Related Stocks

Revvity

Revvity

USRVTY

-2.35%

Danaher

Danaher

USDHR

IDEXX Labs

IDEXX Labs

USIDXX

LongbridgeAI